Photo from academic.microsoft.com
Multiparametric MRI (mpMRI) has revolutionized prostate cancer diagnosis and risk stratification, but the question remains regarding what it is that we see (or don’t see) on mpMRI. A new study… Click to show full abstract
Multiparametric MRI (mpMRI) has revolutionized prostate cancer diagnosis and risk stratification, but the question remains regarding what it is that we see (or don’t see) on mpMRI. A new study by Houlahan and colleagues now offers insight into the molecular characteristics of a tumour that influence mpMRI visibility.
Keywords:
see see;
cancer visible;
prostate cancer;
renders prostate;
see renders
Journal Title: Nature Reviews Urology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Reviews Urology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!